Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells

Biomaterials

Volumn 34, Issue 16, 2013, Pages 4002-4012

  Montanucci, Pia ^a   Pennoni, Ilaria ^a   Pescara, Teresa ^a   Basta, Giuseppe ^a   Calafiore, Riccardo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Alginate; Cell therapy; Diabetes; Fetal liver; Microencapsulation; Transplantation

Indexed keywords

ALGINATE-BASED MICROCAPSULES; CELL THERAPY; DIABETES MELLITUS; FETAL LIVER; INSULIN PRODUCING CELLS; PHYSIOLOGICAL GLUCOSE; TRANSCRIPTIONAL FACTORS; TYPE 1 DIABETES MELLITUS;

ALGINATE; BIOMATERIALS; CYTOLOGY; GENE EXPRESSION; INSULIN; MEDICAL PROBLEMS; MICROENCAPSULATION; PHYSIOLOGICAL MODELS; STEM CELLS; TRANSPLANTATION (SURGICAL);

MOLECULAR BIOLOGY;

ALGINIC ACID; TRANSCRIPTION FACTOR PDX 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ENGINEERING; CELL MANIPULATION; CELL STIMULATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; ENGRAFTMENT; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; LIVER CELL; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL;

ADIPOGENESIS; ANIMALS; CELL AGGREGATION; DIABETES MELLITUS, EXPERIMENTAL; DRUG COMPOUNDING; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; HEPATOCYTES; HUMANS; INSULIN; LIVER; MALE; MICE; MICE, INBRED NOD; MULTIPOTENT STEM CELLS; NEUROGENESIS; OSTEOGENESIS; PHENOTYPE; STEM CELL FACTOR;

ANIMALIA;

EID: 84874998976     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.02.026     Document Type: Article

References (42)

1. Calafiore R., Basta G., Luca G., Lemmi A., Racanicchi L., Mancuso F., et al. Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant Proc 2006, 38:1156-1157.
2. Abraham E.J., Leech C.A., Lin J.C., Zulewski H., Habener J.F. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology 2002, 143:3152-3161.
3. Zalzman M., Anker-Kitai L., Efrat S. Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype. Diabetes 2005, 54:2568-2575.
4. Carpenedo R.L., Sargent C.Y., McDevitt T.C. Rotary suspension culture enhances the efficiency, yield, and homogeneity of embryoid body differentiation. Stem Cells 2007, 25:2224-2234.
5. Kurosawa H. Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. J Biosci Bioeng 2007, 103:389-398.
6. Baraniak P.R., McDevitt T.C. Scaffold-free culture of mesenchymal stem cell spheroids in suspension preserves multilineage potential. Cell Tissue Res 2012, 347:701-711.
7. Bartosh T.J., Ylöstalo J.H., Mohammadipoor A., Bazhanov N., Coble K., Claypool K., et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A 2010, 107:13724-13729.
8. Frith J.E., Thomson B., Genever P.G. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 2010, 16:735-749.
9. Bratt-Leal A.M., Carpenedo R.L., McDevitt T.C. Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog 2009, 25:43-51.
10. Sachlos E., Auguste D.T. Embryoid body morphology influences diffusive transport of inductive biochemicals: a strategy for stem cell differentiation. Biomaterials 2008, 29:4471-4480.
11. Montanucci P., Pennoni I., Pescara T., Blasi P., Bistoni G., Basta G., et al. The functional performance of microencapsulated human pancreatic islet-derived precursor cells. Biomaterials 2011, 32:9254-9262.
12. Montanucci P., Basta G., Pescara T., Pennoni I., Di Giovanni F., Calafiore R. New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly. Tissue Eng Part A 2011, 17:2651-2661.
13. Rogers G.J., Hodgkin M.N., Squires P.E. E-cadherin and cell adhesion: a role in architecture and function in the pancreatic islet. Cell Physiol Biochem 2007, 20:987-994.
14. Dahl U., Sjodin A., Semb H. Cadherins regulate aggregation of pancreatic b-cells in vivo. Development 1996, 122:2895-2902.
15. Kelly C., McClenaghan N.H., Flatt P.R. Role of islet structure and cellular interactions in the control of insulin secretion. Islets 2011, 3:41-47.
16. Aviv V., Meivar-Levy I., Rachmut I.H., Rubinek T., Mor E., Ferber S., et al. Exendin-4 promotes liver cell proliferation and enhances the PDX-1-induced liver to pancreas transdifferentiation process. J Biol Chem 2009, 284:33509-33520.
17. Sapir T., Shternhall K., Meivar-Levy I., Blumenfeld T., Cohen H., Skutelsky E., et al. Cell-replacement therapy for diabetes: generating functional insulin-producing issue from adult human liver cells. Proc Natl Acad Sci U S A 2005, 102:7964-7969.
18. Meivar-Levy I., Sapir T., Berneman D., Weissbach T., Polak-Charcon S., Ravassard P., et al. Human liver cells expressing albumin and mesenchymal characteristics give rise to insulin-producing cells. J Transplant 2011, 2011:252387-252590.
19. Dubiel E.A., Kuehn C., Wang R., Vermette P. In vitro morphogenesis of PANC-1 cells into islet-like aggregates using RGD-covered dextran derivative surfaces. Colloids Surf B Biointerfaces 2012, 89:117-125.
20. Zalzman M., Gupta S., Giri R.K., Berkovich I., Sappal B.S., Karnieli O., et al. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc Natl Acad Sci U S A 2003, 100:7253-7258.
21. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
22. Woodbury D., Schwarz E.J., Prockop D.J., Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000, 61:364-370.
23. ASTM F2064-00(2006)e1 Standard guide for characterization and testing of alginates as starting materials intended for use in biomedical and tissue-engineered medical products application.
24. Montanucci P., Basta G., Calafiore R. In vitro-cultured human islet cell monolayers: stemness markers and insulin recovery upon streptozotocin exposure. Tissue Eng Part A 2009, 15:3931-3942.
25. Hopcroft D.W., Mason D.R., Scott R.S. Structure-function relationships in pancreatic islets: support for intraislet modulation of insulin secretion. Endocrinology 1985, 117:2073-2080.
26. Konstantinova I., Nikolova G., Ohara-Imaizumi M. EphA-Ephrin-A-mediated β cell communication regulates insulin secretion from pancreatic islets. Cell 2007, 129:359-370.
27. Vozzi C., Ullrich S., Charollais A., Philippe J., Orci L., Meda P. Adequate connexin-mediated coupling is required for proper insulin production. J Cell Biol 1995, 131:1561-1572.
28. Artner I., Blanchi B., Raum J.C., Guo M., Kaneko T., Cordes S., et al. MafB is required for islet beta cell maturation. Proc Natl Acad Sci U S A 2007, 104:3853-3858.
29. Matsuoka T.A., Artner I., Henderson E., Means A., Sander M., Stein R. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc Natl Acad Sci U S A 2004, 101:2930-2933.
30. Olbrot M., Rud J., Moss L.G., Sharma A. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci U S A 2002, 99:6737-6742.
31. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., et al. Nat Biotechnol 2006, 24:1392-1401.
32. Torii S. Expression and function of IA-2 family proteins, unique neuroendocrine-specific protein-tyrosine phosphatases. Endocr J 2009, 56:639-648.
33. Dor Y., Brown J., Martinez O.I., Melton D.A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429:41-46.
34. Schulz T.C., Young H.Y., Agulnick A.D., Babin M.J., Baetge E.E., Bang A.G., et al. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One 2012, 7:e37004.
35. Wang X., Wang W., Ma J., Guo X., Yu X., Ma X. Proliferation and differentiation of mouse embryonic stem cells in APA microcapsule: a model for studying the interaction between stem cells and their niche. Biotechnol Prog 2006, 22:791-800.
36. Kelly C., Parke H.G., McCluskey J.T., Flatt P.R., McClenaghan N.H. The role of glucagon- and somatostatin-secreting cells in the regulation of insulin release and beta-cell function in heterotypic pseudoislets. Diabetes Metab Res Rev 2010, 26:525-533.
37. Calabrese A., Caton D., Meda P. Differentiating the effects of Cx36 and E-cadherin for proper insulin secretion of MIN6 cells. Exp Cell Res 2004, 294:379-391.
38. Mandelbaum A.D., Melkman-Zehavi T., Oren R., Kredo-Russo S., Nir T., Dor Y., et al. Dysregulation of dicer1 in beta cells impairs islet architecture and glucose metabolism. Exp Diabetes Res 2012, 2012:470302.
39. Rogers G.J., Hodgkin M.N., Squires P.E. E-cadherin and cell adhesion: a role in architecture and function in the pancreatic islet. Cell Physiol Biochem 2007, 19:987-994.
40. Weber L.M., Hayda K.N., Anseth K.S. Cell-matrix interactions improve b-cell survival and insulin secretion in three-dimensional culture. Tissue Eng Part A 2008, 14:1959-1968.
41. Beattie G.M., Rubin J.S., Mally M.I., Otonkoski T., Hayek A. Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes 1996, 45:1223-1228.
42. Bavamian S., Klee P., Britan A., Populaire C., Caille D., Cancela J., et al. Islet-cell-to-cell communication as basis for normal insulin secretion. Diabetes Obes Metab 2007, 9:118-132.